Head And Neck Carcinoma clinical trials

Explore recruiting head and neck carcinoma clinical trials.

Recruiting head and neck carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Head And Neck Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Accelerator-based BNCT for head and neck carcinoma

Finland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Prostate-specific membrane antigen in thyroid and head and neck carcinoma: On the utility of [18F]AlF-PSMA-11 PET in advanced disease

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Etude évaluant l’imagerie proche infrarouge couplée au vert d’indocyanine pour le contrôle peropératoire des marges de résection en chirurgie ORL (MAGNOLIA)

France, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

LYSARI – LYmphocyte-Sparing And Radio-Immunotherapy in Head and neck carcinoma - A multicenter, randomised 2*2 factorial design comparing standard to reduced-target volume radiotherapy with or without all-trans retinoic acid (ATRA) in patients with lateralised oropharyngeal, laryngeal and hypopharyngeal squamous cell carcinoma.

Belgium, France, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

France, Germany, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

An open-label, multicentric, phase I study with expansion cohorts, evaluating the safety and the efficacy of combination of atezolizumab, tiragolumab and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Head And Neck Carcinoma trials by city

Head And Neck Carcinoma in Toronto Head And Neck Carcinoma in Vancouver Head And Neck Carcinoma in Montreal Head And Neck Carcinoma in Calgary Head And Neck Carcinoma in Edmonton Head And Neck Carcinoma in Ottawa Head And Neck Carcinoma in Winnipeg Head And Neck Carcinoma in Quebec City Head And Neck Carcinoma in Hamilton Head And Neck Carcinoma in Kitchener Head And Neck Carcinoma in London Head And Neck Carcinoma in Halifax Head And Neck Carcinoma in New York Head And Neck Carcinoma in Los Angeles Head And Neck Carcinoma in Chicago Head And Neck Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease